China National Medicines Corporation Ltd. (SHA: 600511)
China flag China · Delayed Price · Currency is CNY
34.42
-0.70 (-1.99%)
Nov 13, 2024, 3:00 PM CST

China National Medicines Corporation Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
2,1652,1461,9641,7541,3831,604
Upgrade
Depreciation & Amortization
192.82192.82189.61178.83172.6130.27
Upgrade
Other Amortization
15.7415.747.84-5.134.94
Upgrade
Loss (Gain) From Sale of Assets
-0.08-0.08-1.68--0.070.53
Upgrade
Asset Writedown & Restructuring Costs
-0.33-0.335.23-6.50.1
Upgrade
Loss (Gain) From Sale of Investments
-369.77-369.77-291.62--220.6-114.59
Upgrade
Provision & Write-off of Bad Debts
9.179.1723.8-9.3215.97
Upgrade
Other Operating Activities
-829.71228.33203.3724.54164.44309.77
Upgrade
Change in Accounts Receivable
-292.55-292.55599.77--107.14-1,633
Upgrade
Change in Inventory
-243.6-243.6-207.59-300.41-12.95
Upgrade
Change in Accounts Payable
1,0481,048-87.62--411.411,511
Upgrade
Change in Other Net Operating Assets
----0.770.3
Upgrade
Operating Cash Flow
1,6882,7272,3951,9571,3021,776
Upgrade
Operating Cash Flow Growth
-35.14%13.84%22.36%50.38%-26.71%80.93%
Upgrade
Capital Expenditures
-147.92-145.12-129.78-95.07-69.05-85.72
Upgrade
Sale of Property, Plant & Equipment
0.360.163.520.781.30.93
Upgrade
Cash Acquisitions
---15.2-15.821.21-31.81
Upgrade
Investment in Securities
21.87.88-12.6-15.752.87-0.9
Upgrade
Other Investing Activities
-61.027.771.742.867.21132.16
Upgrade
Investing Cash Flow
-186.78-129.31-152.32-122.99-56.4714.66
Upgrade
Short-Term Debt Issued
-203.2335.61793.181,184830.58
Upgrade
Total Debt Issued
255.55203.2335.61793.181,184830.58
Upgrade
Short-Term Debt Repaid
--250-509.86-864.55-1,061-1,508
Upgrade
Long-Term Debt Repaid
--81.71-117.07-72.35-60.05-34.95
Upgrade
Total Debt Repaid
-347.7-331.71-626.93-936.91-1,121-1,542
Upgrade
Net Debt Issued (Repaid)
-92.14-128.51-291.32-143.7262.86-711.92
Upgrade
Repurchase of Common Stock
------0
Upgrade
Common Dividends Paid
-751.23-709.58-611.96-637.77-613.06-457.88
Upgrade
Other Financing Activities
-297.86205.91263.7135.53-180.41-47.02
Upgrade
Financing Cash Flow
-1,141-632.18-639.57-745.96-730.61-1,217
Upgrade
Foreign Exchange Rate Adjustments
-----0.02-0.68
Upgrade
Net Cash Flow
359.591,9651,6031,088514.57573.23
Upgrade
Free Cash Flow
1,5402,5822,2651,8621,2331,690
Upgrade
Free Cash Flow Growth
-37.56%13.96%21.64%51.09%-27.08%99.05%
Upgrade
Free Cash Flow Margin
3.01%5.19%4.98%4.01%3.05%3.79%
Upgrade
Free Cash Flow Per Share
2.043.423.002.471.632.22
Upgrade
Cash Income Tax Paid
1,5921,4501,3501,3001,2481,220
Upgrade
Levered Free Cash Flow
497.582,1862,0731,497623.651,259
Upgrade
Unlevered Free Cash Flow
510.512,2062,0891,524659.161,289
Upgrade
Change in Net Working Capital
988.08-659.09-572.62-156.24428.1178.77
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.